726-88-5 Usage
Description
(4-METHYL-2,5-DIOXO-4-PHENYLIMIDAZOLIDIN-1-YL)ACETIC ACID is a synthetic compound belonging to the imidazolidine class, known for its diverse pharmacological properties such as antibacterial, antiviral, and anti-inflammatory activities. (4-METHYL-2,5-DIOXO-4-PHENYLIMIDAZOLIDIN-1-YL)ACETIC ACID features a unique structure with a phenylimidazolidine ring and a methyl group, which may contribute to its biological effects. Ongoing research is exploring its specific pharmacological and toxicological properties, with the potential for development as a new therapeutic agent for various medical conditions.
Uses
Used in Pharmaceutical Industry:
(4-METHYL-2,5-DIOXO-4-PHENYLIMIDAZOLIDIN-1-YL)ACETIC ACID is used as a potential therapeutic agent for various medical conditions due to its diverse pharmacological properties, including antibacterial, antiviral, and anti-inflammatory activities. Its unique structure with a phenylimidazolidine ring and a methyl group may enhance its biological effects, making it a promising candidate for further research and development in the pharmaceutical field.
Check Digit Verification of cas no
The CAS Registry Mumber 726-88-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,2 and 6 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 726-88:
(5*7)+(4*2)+(3*6)+(2*8)+(1*8)=85
85 % 10 = 5
So 726-88-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O4/c1-12(8-5-3-2-4-6-8)10(17)14(7-9(15)16)11(18)13-12/h2-6H,7H2,1H3,(H,13,18)(H,15,16)/p-1/t12-/m1/s1
726-88-5Relevant articles and documents
HAT INHIBITORS AND METHODS FOR THEIR USE
-
Page/Page column 56; 57, (2016/04/10)
Compounds having a structure of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R3c, R4a, R4b, R5, R6, Z and X are as defined herein are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.
